Article Sidebar
Published:
Mar 15, 2019Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Role of Notch signaling pathway in bone marrow mesenchymal stem cell therapy for phosgene inhalationinduced lung injury in rats
Abstract
Methods: Wistar rats (220 - 280 g) were randomly assigned to air inhalation group, phosgene inhalation group, and mesenchymal stem cell (MSC) intervention group. Each group had 8 rats. Directional flow phosgene inhalation device was used to produce phosgene inhalation-induced lung injury in the rats. Serum inflammatory cytokines (TNF-α, IL-8 and IL-6) were determined using ELISA assay kits. The expressions of proteins related to the NSP (Notch1, Notch2, Hes1, Hes5) were quantified using Western blot.
Results: Phosgene inhalation brought about significant increase in TNF-α, IL-8 and IL-6 levels (p < 0.01), but MSC intervention significantly reduced the expressions of these inflammatory factors to varying degrees (p < 0.05), although their levels were still significantly high, relative to the air inhalation group. Results from western blot showed that the Notch1, Notch2, Hes1 and Hes5 were upregulated in the phosgene inhalation group, when relative to the air inhalation group (p < 0.01). Protein expressions in the MSC intervention group were lower than those in the non-intervention groups (p < 0.05).
Conclusion: Phosgene inhalation activates Notch signaling pathway, while MSC intervention inhibits this signaling pathway. Thus, inhibition of NSP may be implicated in the protective effect of MSC therapy against phosgene-induced lung injury.
Keywords: Phosgene, Lung injury, Notch signalling pathway, Mesenchymal stem cells
